TY - JOUR
T1 - Genes contributing to prion pathogenesis
AU - Tamgüney, Gültekin
AU - Giles, Kurt
AU - Glidden, David V.
AU - Lessard, Pierre
AU - Wille, Holger
AU - Tremblay, Patrick
AU - Groth, Darlene F.
AU - Yehiely, Fruma
AU - Korth, Carsten
AU - Moore, Richard C.
AU - Tatzelt, Jörg
AU - Rubinstein, Eric
AU - Boucheix, Claude
AU - Yang, Xiaoping
AU - Stanley, Pamela
AU - Lisanti, Michael P.
AU - Dwek, Raymond A.
AU - Rudd, Pauline M.
AU - Moskovitz, Jackob
AU - Epstein, Charles J.
AU - Cruz, Tracey Dawson
AU - Kuziel, William A.
AU - Maeda, Nobuyo
AU - Sap, Jan
AU - Ashe, Karen Hsiao
AU - Carlson, George A.
AU - Tesseur, Ina
AU - Wyss-Coray, Tony
AU - Mucke, Lennart
AU - Weisgraber, Karl H.
AU - Mahley, Robert W.
AU - Cohen, Fred E.
AU - Prusiner, Stanley B.
PY - 2008/7
Y1 - 2008/7
N2 - Prion diseases are caused by conversion of a normally folded, non-pathogenic isoform of the prion protein (PrPC) to a misfolded, pathogenic isoform (PrPSc). Prion inoculation experiments in mice expressing homologous PrPC molecules on different genetic backgrounds displayed different incubation times, indicating that the conversion reaction may be influenced by other gene products. To identify genes that contribute to prion pathogenesis, we analysed incubation times of prions in mice in which the gene product was inactivated, knocked out or overexpressed. We tested 20 candidate genes, because their products either colocalize with PrP, are associated with Alzheimer's disease, are elevated during prion disease, or function in PrP-mediated signalling, PrP glycosylation, or protein maintenance. Whereas some of the candidates tested may have a role in the normal function of PrPC, our data show that many genes previously implicated in prion replication have no discernible effect on the pathogenesis of prion disease. While most genes tested did not significantly affect survival times, ablation of the amyloid beta (A4) precursor protein (App) or interleukin-1 receptor, type I (II1r1), and transgenic overexpression of human superoxide dismutase 1 (SOD1) prolonged incubation times by 13, 16 and 19%, respectively.
AB - Prion diseases are caused by conversion of a normally folded, non-pathogenic isoform of the prion protein (PrPC) to a misfolded, pathogenic isoform (PrPSc). Prion inoculation experiments in mice expressing homologous PrPC molecules on different genetic backgrounds displayed different incubation times, indicating that the conversion reaction may be influenced by other gene products. To identify genes that contribute to prion pathogenesis, we analysed incubation times of prions in mice in which the gene product was inactivated, knocked out or overexpressed. We tested 20 candidate genes, because their products either colocalize with PrP, are associated with Alzheimer's disease, are elevated during prion disease, or function in PrP-mediated signalling, PrP glycosylation, or protein maintenance. Whereas some of the candidates tested may have a role in the normal function of PrPC, our data show that many genes previously implicated in prion replication have no discernible effect on the pathogenesis of prion disease. While most genes tested did not significantly affect survival times, ablation of the amyloid beta (A4) precursor protein (App) or interleukin-1 receptor, type I (II1r1), and transgenic overexpression of human superoxide dismutase 1 (SOD1) prolonged incubation times by 13, 16 and 19%, respectively.
UR - http://www.scopus.com/inward/record.url?scp=48849094991&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=48849094991&partnerID=8YFLogxK
U2 - 10.1099/vir.0.2008/001255-0
DO - 10.1099/vir.0.2008/001255-0
M3 - Article
C2 - 18559949
AN - SCOPUS:48849094991
SN - 0022-1317
VL - 89
SP - 1777
EP - 1778
JO - Journal of General Virology
JF - Journal of General Virology
IS - 7
ER -